BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34956570)

  • 1. Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca
    Wang X; Zhang W; Na J; Huo Y; Wang Y; Liu K
    J Healthc Eng; 2021; 2021():3843830. PubMed ID: 34956570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling.
    Tsai CY; Kuo WW; Shibu MA; Lin YM; Liu CN; Chen YH; Day CH; Shen CY; Viswanadha VP; Huang CY
    PLoS One; 2017; 12(9):e0184153. PubMed ID: 28863192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.
    Zhang Q; Qi H; Cao Y; Shi P; Song C; Ba L; Chen Y; Gao J; Li S; Li B; Sun H
    J Cell Mol Med; 2018 Dec; 22(12):6055-6067. PubMed ID: 30299584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulinic Acid Improves Cardiac-Renal Dysfunction Caused by Hypertrophy through Calcineurin-NFATc3 Signaling.
    Hong MH; Na SW; Jang YJ; Yoon JJ; Lee YJ; Lee HS; Kim HY; Kang DG
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Over-expression of BDNF inhibits angiotensin II-induced apoptosis of cardiomyocytes in SD rats].
    Cao J; Wu Y; Liu G; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):218-224. PubMed ID: 29773102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3.
    Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y
    Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.
    Weng YS; Wang HF; Pai PY; Jong GP; Lai CH; Chung LC; Hsieh DJ; HsuanDay C; Kuo WW; Huang CY
    Am J Chin Med; 2015; 43(8):1567-91. PubMed ID: 26621443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].
    Wu Y; Wang YQ; Wang BX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):507-13. PubMed ID: 24113045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
    Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
    Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
    Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.